Sarah H Johnson Selected Research

Sarah H Johnson Research Topics

24	Neoplasms (Cancer) 01/2023 - 01/2011
6	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 10/2012
2	Mesothelioma 01/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2014
2	Adenocarcinoma of Lung 11/2016 - 03/2015
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Glioma (Gliomas) 01/2020
1	Malignant Mesothelioma 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Rhabdomyosarcoma 01/2019
1	Alveolar Rhabdomyosarcoma 01/2019
1	Neuroendocrine Carcinoma 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Carcinogenesis 12/2018
1	Rare Diseases (Rare Disease) 01/2017
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016
1	Genetic Translocation (Chromosomal Translocation) 11/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2013
1	Hematologic Neoplasms (Hematological Malignancy) 11/2013
1	Disease Progression 06/2013
1	Lymphoma (Lymphomas) 01/2011

8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2012
6	Proteins (Proteins, Gene)FDA Link 05/2021 - 11/2013
4	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2013
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	Hormones (Hormone)IBA 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2012
2	Anaplastic Lymphoma KinaseIBA 11/2016 - 11/2013
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	Decitabine FDA Link 01/2023
1	IpilimumabIBA 01/2023
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2023
1	ChromatinIBA 01/2023
1	NivolumabIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 09/2022
1	VaccinesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	AntigensIBA 01/2020
1	SynaptophysinIBA 01/2019
1	AsbestosIBA 01/2019
1	CarcinogensIBA 01/2019
1	ChromograninsIBA 01/2019
1	DesminIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	MyogeninIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2018
1	Coloring Agents (Dyes)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2016
1	AndrogensIBA 01/2015
1	PoisonsIBA 01/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2015
1	Fluconazole (Zonal)FDA LinkGeneric 06/2014
1	TNF Receptor-Associated Factor 1IBA 11/2013
1	GP 4 (GP4)IBA 06/2013
1	MicroRNAs (MicroRNA)IBA 01/2011

9	Therapeutics 01/2023 - 01/2015
6	Lasers (Laser) 01/2017 - 10/2012
2	Prostatectomy (Retropubic Prostatectomy) 11/2017 - 02/2016
1	Immunotherapy 01/2023
1	Drug Therapy (Chemotherapy) 05/2021
1	Precision Medicine 01/2020